D2.1 Requirements and Specification - CORBYS
D2.1 Requirements and Specification - CORBYS
D2.1 Requirements and Specification - CORBYS
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>D2.1</strong> <strong>Requirements</strong> <strong>and</strong> <strong>Specification</strong><br />
35. HSS34: Physiological sensor biocompatibility issues<br />
36. HSS36: Physiological sensor hygienic issues<br />
37. MPD10: Patient stability<br />
4.5.3 Second Demonstrator: Robotic Systems for examining Hazardous Environments<br />
38. EASD1: Detailed specification of the evaluation scenarios.<br />
39. EASD2: Integration (wrapping) of modules of existing control architecture (e.g. robot arm control<br />
module) of the second demonstrator into <strong>CORBYS</strong> control architecture.<br />
40. EASD3: Analysis of usability of existing sensors for <strong>CORBYS</strong> demonstration<br />
41. EASD4: Situation Awareness<br />
42. EASD5: Identification <strong>and</strong> anticipation of human co-worker purposeful behaviour<br />
43. EASD6: Extension of existing sensor modules (e.g. vision)<br />
44. EASD7: Evaluation of <strong>CORBYS</strong> cognitive control architecture on the existing robotic system<br />
4.6 StateoftheMarket<br />
This section presents a state-of-the-market on systems relevant to <strong>CORBYS</strong>. In the first subsection, focus is<br />
given to the market for gait rehabilitation systems, <strong>and</strong> in the second subsection, focus is shifted to the market<br />
for autonomous robotic systems for assistance of humans in examining hazardous areas.<br />
4.6.1 First Demonstrator: Mobile Robotassisted Gait Rehabilitation System<br />
The following subsections reports statistics on the neurological conditions identified by the clinical partners in<br />
the <strong>CORBYS</strong> Consortium as most relevant in terms of the application of <strong>CORBYS</strong> technologies to be<br />
developed, to gait rehabilitation for patients suffering from these conditions.<br />
4.6.1.1 Stroke<br />
Table 1 below shows data from the WHO-MONICA Project (WHO MONICA Project cited in Major <strong>and</strong><br />
Chronic Diseases Report 2007) reported for the age range 35-64 years as to mean stroke event rates derived<br />
from the last 3 years of surveillance. Annual change in stroke events <strong>and</strong> 28-days case fatality are also<br />
reported (Major <strong>and</strong> Chronic Diseases Report 2007).<br />
Table 1: WHO-MONICA Project 6 EU population.<br />
Age-st<strong>and</strong>ardised average attack rate per stroke events (fatal <strong>and</strong> non fatal) per 100,000: mean of the last 3 years of the 10year<br />
surveillance in men <strong>and</strong> women ages 35-64 years; 28-day case fatality; average annual trend in 10 years of stroke events.<br />
21
Change language